- 12 August
-
Experts from the Russian Ministry of Health have included the TRIAZAVIRIN® antiviral drug in the guidelines «Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection COVID-19» (version No. 19 dated 27/5/2025).
- 17 June
-
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
- 13 June
-
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
- 10 June
-
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
- Home
- Cluster members
- The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary»
The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary»
The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary» is the leading medical center in the region providiry specialized high-tech healthcare assistance for the oncological patients at Sverdlovsk region.
The Sverdlovsk Regional Oncological Dispensary is the participant of the national project «Healthcare», the federal project «Fight against oncological diseases», the largest oncological clinic in the Middle Urals and the head institution of the oncological service of the Sverdlovsk region. All modern methods for the diagnostic and treatment of available on the base of the oncological center.
Every year, medical staff performs over 22 400 surgeries, 29 200 chemotherapy courses and 8 100 radiation therapy courses actually.
The potential of medicine grows. The issues of early diagnosis and treatment of malignant neoplasms are of particular interest. Sverdlovsk oncologists improve their knowledge and skills at all-Russian and international scientific forums, conferences, symposiums. Specialists of oncological dispensary teach general practicants in new methods of treating and diagnosing oncological diseases, and conduct classes for patients and their relatives.
The oncological dispensary aim is to make modern medical oncological care affordable and of high quality. The Sverdlovsk Regional Oncology Center is focused on the highest world standards.
The Sverdlovsk Regional Oncological Dispensary branches in Yekaterinburg, Branch №1 in the city of Nizhny Tagil and Branch №2 in the city of Kamensk-Uralsky.
